Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVernalis PLC Regulatory News (VER)

  • There is currently no data for VER

Form 8.5 (EPT/RI)

29 May 2018 16:38

RNS Number : 5841P
Canaccord Genuity Limited
29 May 2018
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Canaccord Genuity Limited

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Vernalis Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Connected party to the Offeree

 

(d) Date dealing undertaken:

25 May 2018

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

No

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

Ord 1p

 

 

Buy

200

 

7p

 

 

7p

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

Date of disclosure:

29 May 2018

Contact name:

Sam Cooke

Telephone number:

020 7523 4658

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERFMGZKKLVGRZM
Date   Source Headline
12th Nov 20073:13 pmRNSPresent at PJ Conference
12th Nov 200710:35 amRNSDirector/PDMR Shareholding
25th Oct 200712:43 pmRNSDirector/PDMR Shareholding
4th Oct 200712:36 pmRNSDirector/PDMR Shareholding
3rd Oct 200711:18 amRNSDirector/PDMR Shareholding
1st Oct 20077:00 amRNSAction Letter from FDA
13th Sep 20077:01 amRNSPhase I Study - V24343
13th Sep 20077:01 amRNSInterim Results
10th Sep 20075:26 pmRNSNotice of Results
10th Sep 200712:00 pmRNSFROVA
3rd Sep 20077:00 amRNSMilestone payment
28th Aug 20077:02 amRNSDeparture of Board Member
17th Aug 20077:01 amRNSUpdate on Frova
7th Aug 20072:03 pmRNSAnnual Information Update
2nd Aug 20074:06 pmRNSHolding(s) in Company
16th Jul 20077:01 amRNSPHASE IIA TRIAL OF V3381
11th Jun 20077:02 amRNSFrova Phase III Data
6th Jun 20072:28 pmRNSDirector/PDMR Shareholding
4th Jun 20073:08 pmRNSDirector's share dealing
23rd May 200711:49 amRNSAGM Statement
17th May 20077:01 amRNSDrug Discovery Collaboration
8th May 20077:01 amRNSBiogen Idec and Vernalis
24th Apr 200711:00 amRNSNasdaq Stock Market
20th Apr 20073:40 pmRNSHolding(s) in Company
22nd Mar 20075:14 pmRNSHolding(s) in Company
16th Mar 200711:44 amRNSPDUFA date for Frova(R) SNDA
12th Mar 20077:03 amRNSFrova(R) in France
12th Mar 20077:03 amRNSPreliminary Results
29th Jan 200712:24 pmRNSHolding(s) in Company
29th Jan 20077:01 amRNSNotice of Results
20th Dec 200611:34 amRNSTotal Voting Rights
20th Dec 20069:50 amRNSAppointment of Ian Clark
11th Dec 20067:00 amRNSPhase I Trial of V24343
21st Nov 20067:00 amRNSPiper Jaffray Healthcare Conf
20th Nov 20067:00 amRNSOncology Hsp90 Programme
2nd Nov 20067:00 amRNSGlobal Health Care Conference
20th Sep 200612:09 pmRNSUBS Global Life Sciences Conf
20th Sep 20067:01 amRNSFiling of Frova(R)
13th Sep 20067:00 amRNSDirector/PDMR Shareholding
12th Sep 20067:03 amRNSInterim Results
23rd Aug 20067:01 amRNSNotice of Results
3rd Aug 20067:00 amRNSPhase IIa Trial of V3381
28th Jul 200612:00 pmRNSAdditional Listing
20th Jul 20067:00 amRNSsNDA for Frova
5th Jul 20063:17 pmRNSHolding(s) in Company
19th Jun 200611:00 amRNSInvestor Conferences
24th May 20062:00 pmRNSRESULTS OF THE AGM
15th May 20067:00 amRNSVernalis Rings NASDAQ Bell
8th May 20067:02 amRNSFrova Phase III Study
6th Apr 20066:14 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.